at 23:11 |
|
|
TransCode Therapeutics, Inc. , the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that it has agreed to sell an aggregate of 10,250,000 shares of its common stock and warrants to purchase up...
|
at 23:00 |
|
|
Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, announced on March 21st, 2025 its financial results for fiscal year 2024, reporting total revenue of RMB 2.7 billion, representing an 11.2%...
|
at 22:00 |
|
|
HashKey Chain announced that the tokenized USD Money Market Fund, "CPIC Estable MMF", initiated and managed by CPIC Investment Management (H.K.) Co, Ltd, was successfully deployed on HashKey Chain, with subscription volume reaching USD 100 million on...
|
at 22:00 |
|
|
Impact fund manager Abler Nordic has partnered with Temasek Foundation, a Singapore-based philanthropic organisation that drives impact programmes in Asia, together with sustainable palm oil producer Musim Mas, and Livelihoods Funds to launch the...
|
at 20:30 |
|
|
WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has received 2025 CDMO Leadership Awards in the "Biologics - Global" category. It has also been...
|
at 20:16 |
|
|
G2S2 Capital Inc. ("G2S2") announces that its wholly owned subsidiary has disposed of common shares ("Shares") of Knight Therapeutics Inc. ("Knight") and no longer holds over 10% of Knight's outstanding Shares....
|
|
|